Back to courses

Advances in Rheumatology 2023

This is a fully virtual event

Description

For more than 40 years, “Advances in Rheumatology” has been influential in educating generations of clinicians on over 100 rheumatic conditions, which now encompass the specialty. A collaboration between Harvard Medical School’s two largest teaching hospitals, the Massachusetts General Hospital and Brigham and Women’s Hospital, the course not only focuses on rheumatic diseases, but offers additional perspectives from other medical disciplines, such as pulmonology, dermatology, oncology, ophthalmology, and endocrinology. “Advances in Rheumatology” targets the practicing clinician seeking to enhance their clinical skills and increase their knowledge with the latest breakthroughs in the diagnosis, treatment, and pathophysiology of rheumatic diseases.

This three day livestream course will be a combination of sessions formatted with lectures by leading experts on topics pertaining to their special areas of interest, curbside consultations and panel discussions. Topics include The Year in Rheumatology, updates on Giant Cell Arteritis, Orbital Inflammatory Disease, Systemic Sclerosis, Hemophagocytic Syndrome, the New England Journal of Medicine Clinicopathological Conference (CPC)  and various disease focused afternoon sessions such as Lupus, Psoriatic Arthritis and Rheumatoid Arthritis. The full range of rheumatic disease is covered every year over the span of this course.

 

Target audience

This activity is intended for Primary Care Physicians, Specialty Physicians, Nurse Practitioners, Physician Assistants, Dermatology, Endocrinology, Family Medicine, Infectious Disease, Internal Medicine, Oncology and Hematology, Ophthalmology, Orthopedics, Pathology, Preventative Medicine, Pulmonary Medicine, Rheumatology, Urology, Allergy and Immunology.

Learning objectives

Upon completion of Advances in Rheumatology, participants will be able to:

  1. Evaluate the latest scientific advances in the field of rheumatology.
  2. Analyze insights from pathology, immunology, and pharmacology that pertain to specific rheumatologic issues.
  3. Translate the latest developments in the field of rheumatology to clinical practice.
  4. Integrate new treatment approaches for patients with rheumatic disease.
  5. Apply new diagnostic techniques in their patient population.

MOC Completion Criteria

Participant completion for MOC points will be reported to the boards at the conclusion of the course. 

Please have your ABIM ID available when completing the evaluation at the end of the course.

Instructions: Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) Program

Upon successful completion of this activity, if you wish to receive MOC Part 2 points you will need to enter your ABIM ID number in the post-course evaluation. The Mass General Brigham Office of Continuing Professional Development will verify completion of your activity and report to the ABIM. Diplomates must check their ABIM Portfolio for confirmation of your MOC Part 2 points.

 MOC Recognition Statement 
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 22.25 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Funding

Advances in Rheumatology 2023 has received support in the form of an educational grant from the following companies: 
 
AstraZeneca Pharmaceuticals
Bristol Myers Squibb
Janssen Biotech,Inc., administered by Janssen Scientific Affairs, LLC
Novartis

 

Registration instructions

This is a fully virtual event
Registration Type Full Registration Fee
Physician  $600.00
Resident/Fellow $150.00
Nurse $300.00
Other Allied Healthcare Professionals
(Pharmacists, Physician Assistants, PhD)		 $300.00
Industry $800.00

Cancellation Policy:
Registrations cancelled on or before September 29, 2023 will be refunded, less a $60 administrative fee. Registrations cancelled after September 29, 2023 will not be refunded.

Contact partnerscpd@partners.org if you require assistance in cancelling your online registration.

Additional information

Massachusetts General Hospital, Brigham and Women’s Hospital, & Mass General Brigham 

 

Faculty credentials

Advances in Rheumatology Course Directors

John H. Stone, MD, MPH 
Professor of Medicine, Harvard Medical School;
The Edward A. Fox Chair in Medicine, Massachusetts General Hospital

Michael Weinblatt, MD
John R. Riedman Professor of Medicine, Harvard Medical School;
Co-Director, Clinical Rheumatology,
Associate Director, Center for Arthritis and Joint Diseases,
Brigham and Women’s Hospital

 

Advances in Rheumatology Speakers

Rohit Aggarwal MD, MS
University of Pittsburgh

Luke Chen, MD
BC Cancer | Vancouver, BC

Stanley Cohen, MD

Christian Dejaco, MD
Brunico Hospital

Atul Deodhar, MD
Oregon Health & Science University

Thomas Dorner, MD
Charite University Hospital

David Dudzinski, MD, JD
Massachusetts General Hospital

Paul Emery, MD
University of Leeds

Judith Ferry, MD
Massachusetts General Hospital

Ambrose Huang, MD
Massachusetts General Hospital

Laura Hummers, MD
Johns Hopkins University

David Isenberg, MD, FRCP, FAMS
University College London

Michael Jordan, MD
Cincinnati Children’s Hospital

Andreas Kronbichler, MD
Medical University Innsbruck

Katherine Liao, MD
Brigham and Women’s Hospital

Andrew Mammen, MD, PhD
National Institute of Health

Iain B McInnes, CBE, PhD, FRCP, FRSE, FMedSci.
University of Glasgow

Joseph Merola, MD
Brigham and Women’s Hospital

Alexis Ogdie, MD, MSCE
University of Pennsylvania

Julie Paik, MD
Johns Hopkins University

Michelle Petri, MD, MPH
Johns Hopkins University

Brad Rovin, MD
Ohio State University

Ami Shah, MD
Johns Hopkins University

Allen Steere, MD
Massachusetts General Hospital

Ronald van Vollenhofen, MD
University of Amsterdam

Accreditation

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Mass General Brigham designates this live activity for a maximum of 22.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Program

Friday, October 13, 2023 | 7:00am – 5:00pm

7:00am Registration for Advances in Rheumatology
7:30 The Year in Clinical Rheumatology | John H. Stone, MD, MPH
8:30 Giant Cell Arteritis & Polymyalgia Rheumatica: Answering the Currently Critical Questions | Christian Dejaco, MD, PhD, MBA
9:30 Morning Break
9:45 ANCA-Associated Vasculitis: The Nephrologist’s Perspective | Andreas Kronbichler, MD
10:45

New England Journal of Medicine Clinicopathologic Conference | Luke Chen, MD; John H. Stone, MD, MPH; Ambrose Huang, MD; Judith Ferry, MD; David Dudzinski, MD, JD
12:00pm Lunch
Disease Focused Afternoon Session: Lupus Nephritis
1:00 Important Clinical Outcomes in SLE: How are we doing now? | Michelle Petri, MD, MPH 
1:45 B Cell Depletion in Lupus: How will it fit into the current treatment paradigms? | 
David Isenberg, MD, FRCP, FAMS
2:15 Break
2:30 Calcineurin Inhibitors in SLE Nephritis | Brad Rovin, MD
3:00 Novel Treatment Approaches to Lupus | Thomas Dorner, MD
3:30 Break
3:45 Panel Discussion | Michelle Petri, MD MPH; David Isenberg, MD; Brad Rovin, MD;  Thomas Dorner, MD
5:00pm Adjourn

 

Saturday, October 14, 2023 | 7:45am – 4:30pm

7:45am Log-In Time
8:00 The Pathologies of Inflammatory Myopathy |  Andrew Mammen, MD, PhD
8:45 Using Autoantibodies to Parse the Inflammatory Myopathies |  Julie Paik, MD
9:45 Morning Break
10:15 Difficult Myopathies | Rohit Aggarwal, MD, MS
11:00 Challenges in Lyme Disease | Allen Steere, MD
12:00pm Lunch
Disease Focused Afternoon Session: Psoriasis & Psoriatic Arthritis
1:00 Important Outcomes in Psoriasis/ Psoriatic Arthritis: How are we doing now? |
Alexis Ogdie, MD, MSCE
1:30 How does a Rheumatologist approach Psoriasis Treatment? | Joseph Merola, MD
2:00 Break
2:15 Treatment of PsA | Iain B McInnes, CBE, PhD, FRCP, FRSE, FMedSci.
2:45 Treatment of Spondylitis | Atul Deodhar, MD
3:15 Break
3:30 Panel Discussion | Joseph Merola, MD; Iain B McInnes, CBE, PhD, FRCP, FRSE, FMedSci.; Atul Deodhar, MD; Alexis Ogdie, MD, MSCE
4:30pm Adjourn

 

Sunday, October 15, 2023 | 7:15am – 5:00pm

7:15am Log-In 
7:30 Tackling Diffuse Systemic Sclerosis | Ami Shah, MD
8:30 How to Approach Limited Scleroderma Now | Laura Hummers, MD
9:30 Morning Break
9:45 Identifying & Treating the Hemophagocytic Syndrome | Michael Jordan, MD
10:45 A Practical Tour through IgG4-Related Disease: Lessons from the patients over 15 years | John H. Stone, MD, MPH
11:45 Lunch
Disease Focused Afternoon Session: Rheumatoid Arthritis
1:00pm Important Outcomes in RA: How are we doing now? | Katherine Liao, MD
1:30 Methotrexate in Rheumatoid Arthritis | Michael Weinblatt, MD
2:00 Break
2:15 Biologics and Jak Inhibition | Ronald van Vollenhofen, MD
2:45 How does a Rheumatologist approach RA Treatment? (Europe & USA) | Paul Emery, MD (Europe) & Stanley Cohen, MD (Southwestern USA)
3:45 Break
4:00 Panel Discussion | Katherine Liao, MD; Ronald Von Vollenhofen, MD; Paul Emery, MD; Stanley Cohen, MD
5:00pm Adjourn

 

Course Summary
  • Available credit
    22.25 ABIM MOC II
    22.25 AMA PRA Category 1 Credit™
    22.25 Participation
  • Formats
    Online live
  • Categories
    Rheumatology
  • Course opens
    April 7, 2023
  • Course expires
    February 16, 2024
  • Event starts
    October 13, 2023, 11:59 pm EDT
  • Event ends
    October 15, 2023, 5:00 pm EDT
  • Price
    $600.00
  • This course is closed.
Event location
  • This is a live event.
Skip to content